C07C 311/28
Having the sulfur atom of at least one of the sulfonamide groups
Official title: having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
C07C311/28 (Having the sulfur atom of at least one of the sulfonamide groups) appears on 18 US grants and 22 published applications in this corpus.
Search patents in C07C- Granted patents
- 18
- Published applications
- 22
- Assignees
- 10
- Inventors
- 31
- Latest grant
- 11 Apr 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 1 | 0 |
| 2011 | 1 | 1 |
| 2012 | 2 | 4 |
| 2013 | 2 | 4 |
| 2014 | 4 | 3 |
| 2015 | 2 | 4 |
| 2016 | 2 | 2 |
| 2017 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use11 Apr 2017US 9,616,037 B2PIMCO 2664 Limited
- Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use5 Apr 2016US 9,302,984 B2PIMCO 2664 Limited
- Polymerizable monomer, polymeric compound, charge control agent containing the polymeric compound, and developer bearing member and toner which contain the charge control agent2 Feb 2016US 9,250,552 B2Canon Kabushiki Kaisha
- Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof3 Nov 2015US 9,174,933 B2Ardea Biosciences, Inc.
- Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use9 Jun 2015US 9,050,329 B1PIMCO 2664 Limited
- Derivatives of n-(arylamino) sulfonamides as inhibitors of mek29 Jun 2017US 2017/0183333 A1Ardea Biosciences, Inc.
- Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use21 Jul 2016US 2016/0206578 A1PIMCO 2664 Limited
- Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent16 Jun 2016US 2016/0166526 A1Takeda Pharmaceutical Company Limited
- Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use24 Sep 2015US 2015/0266815 A1PIMCO 2664 Limited
- Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent23 Jul 2015US 2015/0203464 A1Takeda Pharmaceutical Company Limited
Most cited
By later US patents
- Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK33US 7,759,518 B2Ardea Biosciences, Inc. · 2010
- Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK28US 8,101,799 B2Ardea Biosciences, Inc. · 2012
- Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof25US 8,044,240 B2Ardea Biosciences, Inc. · 2011
- Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof23US 8,252,842 B2Ardea Biosciences, Inc. · 2012
- Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof23US 8,466,316 B2Ardea Biosciences, Inc. · 2013